WASHINGTON, United States – The Moderna and Merck drug makers on Tuesday announced positive results from a trial in which messenger RNA technology was used for the first time to make personalized vaccines for skin cancer patients. The mRNA technology proved vital in the development of vaccines against Covid-19, and ...